Home / Mesothelioma Treatment / Surgery for Mesothelioma

Surgery for Mesothelioma

Surgical Treatments for Pleural Mesothelioma

There are a variety of surgical procedures and treatments for pleural mesothelioma. Below is an overview of a few of the most frequent ones used in patients.

Pleurocentesis

This procedure is used to minimize pleural effusion, the build-up of fluid in the pleural space surrounding the lungs. The fluid can make it difficult for a mesothelioma patient to breath. The procedure involves the surgical puncture and drainage of the thoracic cavity and is usually performed in an outpatient setting with a long, thin needle that is inserted into the pleural space.

Pleurodesis

Pleurodesis is a surgical procedure that uses chemicals, talc or drugs to scar the space between the layers of the pleura. First, fluid is drained from the space using a catheter or chest tube. Next, the chemical, talc or drug is put into the space. The scarring stops the build-up of fluid in the pleural cavity. This is sometimes referred to as a “talc procedure.”

Pleurectomy / Decortication

Pleurectomy / Decortication refers to a lung-sparring surgery to remove the mesothelioma cancer by removing part of the covering of the lungs, lining of the chest, and part of the outside surface of the lungs. The goals of the operation are to re-expand the lung and remove the disease process affecting the pleural space so that pulmonary (lung) function and symptoms will improve.

Pneumonectomy

A pneumonectomy is a surgery that involves the removal of the lung that has been affected by mesothelioma. It has become the standard surgery for operable locally advanced lung cancer.

Extrapleural Pneumonectomy

An Extrapleural Pneumonectomy or EPP is the most invasive surgery for mesothelioma and involves the removal of the diseased lung, part of the pericardium, (the membrane that covers the heart), part of the diaphragm (the muscle that lies between the abdomen and the lungs), and part of the parietal pleura (this is the membrane that lines the chest). An EPP is typically performed only on patients with early stage localized disease that has not metastasized to the lymph nodes or to other tissues and organs. Sometimes heated chemotherapy is introduced during an EPP in order to bathe affected tissues. Although an EPP can impact life expectancy for some patients, there can be significant risks to this procedure. These risks may include: internal bleeding, respiratory failure, infection and blood clots. In addition, some patients undergoing extrapleural pneumonectomy die during or immediately following the procedure. That percentage is, however, lower at medical centers that specialize in this surgery.

Controversy

Perhaps the greatest area of dispute now is whether an extrapleural pneumonectomy (EPP) or pleurectomy / decortication is the most appropriate curative operation for mesothelioma patients who are candidates for both procedures. There are leading mesothelioma surgeons who take contrary point of view. For example, Dr. Robert Cameron at UCLA has endorsed a lung sparring approach while Dr. David Sugarbaker of Brigham and Women’s Hospital has advocated for EPP. The 2011 MARS study (Mesothelioma and Radical Surgery randomized feasibility study) concluded that, “radical surgery in the form of EPP within trimodal therapy offers no benefit and possibly harms patients.”

Surgical Treatments for Peritoneal Mesothelioma

Paracentesis

Similar to pleurocentesis, paracentesis is a procedure in which fluid from the abdomen is removed through a needle. It is performed on peritoneal mesothelioma patients to remove pressure from the fluid.

Peritonectomy / Cytoreductive Surgery

Peritonectomy is the most common surgical procedure for peritoneal mesothelioma and involves the removal or stripping of the affected peritoneum (cancerous part of the lining of the abdominal cavity) from the underlying tissue. Peritonectomy is usually combined with cytoreductive surgery where the goal is to also remove as much of the cancerous growth as possible from multiple sites in the abdomen. The greater omentum is nearly always involved and has to be removed.

HIPEC

Doctors often perform cytoreductive surgery in combination with other mesothelioma treatments such a chemotherapy. For example, in a HIPEC procedure (heated intraperitoneal chemotherapy), surgeons introduce heated chemotherapy directly into the surgical cavity. In the peer reviewed medical literature, HIPEC procedures used in peritoneal mesothelioma management report superior survival statistics when compared to other surgeries.

Related Posts

Empyema After Mesothelioma Surgery: Avoiding a Serious Complication - A new study of a rare condition called empyema after mesothelioma surgery shows it can dramatically lengthen hospital stay and shorten survival.  Empyema refers to pockets of pus in the pleural space around the lungs. It is the result of a lingering bacterial infection. Empyema is a serious complication in people who have surgery for pleural mesothelioma.  The new study comes from the International Mesothelioma Program at Boston’s Brigham & Women’s Hospital. It finds that patients with empyema after mesothelioma surgery live half as long as those without it. They also spend a lot more time in the hospital.  The researchers say air leaking from the lungs can raise the risk for this complication. In their new report, they offer … Continue reading Empyema After Mesothelioma Surgery: Avoiding a Serious Complication »

Access to Multi-Modality Mesothelioma Treatment Limited for Uninsured & Rural Residents - A new study shows a person’s insurance status and where they live often impact their access to multi-modality mesothelioma treatment. This can have an impact on their survival.  Researchers at the University of Miami Sylvester Comprehensive Cancer Center conducted the new study. They shared their findings at the recent virtual world conference of the International Association for the Study of Lung Cancer.  The study found that access to multi-modality mesothelioma treatment was more common in patients with private insurance or Medicare. It was also more common among those who lived closer to larger medical centers.  People who lived further out or who did not have insurance often did not receive the treatments that offer the best odds of mesothelioma survival. … Continue reading Access to Multi-Modality Mesothelioma Treatment Limited for Uninsured & Rural Residents »

HITOC for Mesothelioma: Benefits May Outweigh the Risk - The benefits of a localized chemotherapy regimen known as HITOC for mesothelioma outweigh the small risk of kidney failure for most patients.  That is the conclusion of a new study published in the journal Cancers. German researchers conducted a retrospective review of the medical literature on HITOC (also called HITHOC) in pleural mesothelioma patients.  They were most interested in patients who developed kidney problems after the procedure. This is a known risk with HITOC for mesothelioma. But the study suggests that most patients benefit from this type of chemotherapy in spite of the risk. Localized Treatment Versus Systemic Treatment Pleural mesothelioma tumors start on the membrane around the lungs and are hard to treat. Once this cancer takes hold, most … Continue reading HITOC for Mesothelioma: Benefits May Outweigh the Risk »

Cancer-Fighting Gel Could “Change the Treatment Paradigm” for Mesothelioma - New National Cancer Institute research shows a cancer-fighting gel applied directly to the surface of a mesothelioma tumor could “change the treatment paradigm” for this troublesome cancer.  NCI researchers in Maryland developed the treatment and tested it in animals with mesothelioma tumors.  Their tests show mesothelioma tumors respond after just one application of the medication.  The authors of a new report on the treatment say surgeons could use it to enhance mesothelioma surgery. They could even use the cancer-fighting gel on its own as a stand-alone therapy.  The Challenge of Mesothelioma Tumor Shape Malignant mesothelioma is a surface malignancy. Surface malignancies are tumors that grow on the surface of other organs or tissues. In the case of mesothelioma, tumors occur … Continue reading Cancer-Fighting Gel Could “Change the Treatment Paradigm” for Mesothelioma »

New Surgical Technique May Support Long-Term Peritoneal Mesothelioma Survival - One of the nation’s top mesothelioma doctors says long-term peritoneal mesothelioma survival is possible with a far-reaching new surgical technique. Dr. Paul Sugarbaker is a surgeon with the Washington Cancer Institute in Washington, DC. He has studied peritoneal mesothelioma for decades.  In a new report, he outlines a case of long-term peritoneal mesothelioma survival in a female patient. The patient had cytoreductive surgery. The surgery included resection of the colonic mesentery. This is tissue that is not normally part of peritoneal mesothelioma surgery.  The case report shows the patient is still cancer-free four years after surgery with an “excellent” quality of life.  The Challenge of Peritoneal Mesothelioma Every year, about 2,500 Americans receive a diagnosis of mesothelioma. Peritoneal mesothelioma accounts … Continue reading New Surgical Technique May Support Long-Term Peritoneal Mesothelioma Survival »

HITHOC for Pleural Mesothelioma: “Safe, Feasible and Effective” - A newly published study says a localized form of chemotherapy called HITHOC for pleural mesothelioma is “safe, feasible, and effective.” Researchers from Italy’s University of Pisa conducted the study. They did a thorough review of the medical literature on the procedure since 1994.  They conclude that HITHOC for pleural mesothelioma after surgery keeps tumors in check and improves survival. The downside is that there is not enough standardization in how doctors use the procedure.  How HITHOC for Pleural Mesothelioma Works HITHOC stands for hyperthermic intrathoracic chemotherapy. Standard mesothelioma chemotherapy enters the whole body at once through the bloodstream. That is one reason that many mesothelioma patients on chemotherapy have side effects like nausea and low white blood cell counts.  HITHOC … Continue reading HITHOC for Pleural Mesothelioma: “Safe, Feasible and Effective” »

Pleural Mesothelioma Patients are Stronger a Year After Surgery - Pleural mesothelioma patients can be stronger and have better lung function a year after surgery than in the days and weeks immediately following their operation. That’s the finding of Japanese researchers who just published a new study in Integrative Cancer Therapies.  They tested 24 male pleural mesothelioma patients in their 60s and 70s. They measured things like the mens’ grip strength, knee extension strength, and how far they could walk in six minutes. They also ran several tests on their lung function. They compared these test results with the patients’ own assessment of their outcomes.  The study suggests that patients who undergo P/D surgery can continue to improve beyond the postoperative phase. It is a hopeful message for patients and … Continue reading Pleural Mesothelioma Patients are Stronger a Year After Surgery »

Physical Function Predicts Mesothelioma Surgery Outcomes - A patient’s level of physical function prior to mesothelioma surgery is a strong predictor of how well they will do after surgery. That is the conclusion of a new University of Maryland study. Researchers analyzed the cases of 54 pleural mesothelioma patients before and after lung-sparing P/D surgery.  The goal was to see what factors had the biggest impact on their post-surgical outcomes. Patients underwent lung function and physical function tests both before and after their operations.  It turns out that a mesothelioma patient’s ability to be physically active is even more important than their lung function in predicting their recovery. Lung-Sparing Pleural Mesothelioma Surgery Pleural mesothelioma is a cancer of the multi-layer membrane (pleura) that surrounds the lungs. As … Continue reading Physical Function Predicts Mesothelioma Surgery Outcomes »

Academic Medical Centers Extend Peritoneal Mesothelioma Survival - A new published study suggests that peritoneal mesothelioma patients treated at academic medical centers survive much longer than those who get their care at community hospitals. The study was conducted by Harvard Medical School researchers at Brigham and Women’s Hospital in Boston.  Peritoneal mesothelioma is a rare and aggressive cancer of abdominal membranes. There is no known cure. The new study compared outcomes and survival among more than 2,600 mesothelioma patients. Patients were treated at high-volume academic hospitals or community cancer centers.  The results suggest that academic medical centers consistently provide more advanced and potentially life-extending care for this complex cancer.  Experience is Critical for Mesothelioma Care Malignant mesothelioma is the name for cancers that occur on internal membranes. It … Continue reading Academic Medical Centers Extend Peritoneal Mesothelioma Survival »

New Study: PD Surgery and HITHOC for Pleural Mesothelioma - German doctors say a combination of extended PD surgery and HITHOC has produced some ‘remarkable’ results for patients with pleural mesothelioma.  Extended PD (pleurectomy with decortication) is a lung-sparing surgical procedure for people with cancer on the pleural membrane around the lungs. HITHOC is a method for infusing the area with heated chemotherapy drugs without sending those drugs through the whole body.  Together, extended PD surgery and HITHOC produced median progression-free survival of more than a year and a half for mesothelioma patients in a new German study. Their experience is the focus of a new article in the journal Respiration.  Removing and Killing Cancer Cells: The One-Two Punch Malignant pleural mesothelioma is a rare cancer that starts on the … Continue reading New Study: PD Surgery and HITHOC for Pleural Mesothelioma »